Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 7/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12198718 | 0.76 | TEAD1 (0.33) | L3MBTL1HSD17B10EPHX2 | |
| SCHEMBL3069167 | 0.75 | EPHX2 (0.70) | L3MBTL1HSD17B10HSD11B1EPHX2NPC1 | |
| SCHEMBL21393268 | 0.75 | EPHX2 (0.39) | L3MBTL1HSD17B10HSD11B1EPHX2EPHX1 | |
| SCHEMBL3805575 | 0.73 | L3MBTL1 (0.59) | L3MBTL1HSD17B10HSD11B1EPHX2NPC1 | |
| SCHEMBL11571965 | 0.72 | EPHX2 (0.45) | L3MBTL1HSD17B10HSD11B1EPHX2NPC1 | |
| Hydrochloric Acid SCHEMBL28791344 | 0.71 | L3MBTL1 (0.57) | L3MBTL1HSD17B10HSD11B1EPHX2NPC1 | |
| SCHEMBL3114854 | 0.71 | L3MBTL1 (0.57) | L3MBTL1HSD17B10HSD11B1EPHX2NPC1 | |
| SCHEMBL1223956 | 0.71 | L3MBTL1 (0.57) | L3MBTL1HSD17B10HSD11B1EPHX2NPC1 | |
| SCHEMBL14420613 | 0.71 | HSD11B1 (0.32) | L3MBTL1HSD17B10HSD11B1EPHX2NPC1 | |
| SCHEMBL15377775 | 0.71 | L3MBTL1 (0.61) | L3MBTL1HSD17B10HSD11B1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150159009-A1 | GRAFT COPOLYMERS, THEIR PREPARATION AND USE IN CAPILLARY ELECTROPHORESIS | APPLIED BIOSYSTEMS LLC (US) | 2015-06-11 | — | — | US | claimed |
| US-20130153421-A1 | GRAFT COPOLYMERS, THEIR PREPARATION AND USE IN CAPILLARY ELECTROPHORESIS | APPLIED BIOSYSTEMS, LLC (US) | 2013-06-20 | — | — | US | claimed |
| EP-2275463-A1 | Support for electrophoresis containing a composition and method | Life Technologies Corporation (US) | 2011-01-19 | — | — | EP | claimed |
| EP-1539846-B1 | GRAFT COPOLYMERS, THEIR PREPARATION AND USE IN CAPILLARY ELECTROPHORESIS | LIFE TECHNOLOGIES CORP (US) | 2010-09-08 | — | — | EP | claimed |
| US-20050234166-A1 | Graft copolymers, their preparation and use in capillary electrophoresis | APPLIED BIOSYSTEMS, INC. | 2005-10-20 | — | — | US | claimed |
| EP-1539846-A1 | GRAFT COPOLYMERS, THEIR PREPARATION AND USE IN CAPILLARY ELECTROPHORESIS | Applera Corporation (US) | 2005-06-15 | — | — | EP | claimed |
| WO-2004011513-A1 | GRAFT COPOLYMERS, THEIR PREPARATION AND USE IN CAPILLARY ELECTROPHORESIS | APPLERA CORPORATION (US) | 2004-02-05 | — | — | WO | claimed |
| US-20250001400-A1 | MATERIAL AND METHOD FOR PERFORMING A SEPARATION BASED ON BORON CLUSTERS | MERCK PATENT GMBH (DE) | 2025-01-02 | — | — | US | disclosed |
| CN-118667344-A | Temperature-sensitive injectable self-healing supermolecule hydrogel based on P (MVE-alt-MA) and preparation method thereof | 中国石油化工股份有限公司 | 2024-09-20 | — | — | CN | disclosed |
| EP-4429811-A1 | MATERIAL AND METHOD FOR PERFORMING A SEPARATION BASED ON BORON CLUSTERS | Merck Patent GmbH (DE) | 2024-09-18 | — | — | EP | disclosed |
| WO-2023079136-A1 | MATERIAL AND METHOD FOR PERFORMING A SEPARATION BASED ON BORON CLUSTERS | MERCK PATENT GMBH (DE) | 2023-05-11 | — | — | WO | disclosed |
| US-20190293641-A1 | ASSAY | IMPERIAL COLLEGE INNOVATIONS, LTD. (GB) | 2019-09-26 | — | — | US | disclosed |
| US-20150159009-A1 | GRAFT COPOLYMERS, THEIR PREPARATION AND USE IN CAPILLARY ELECTROPHORESIS | APPLIED BIOSYSTEMS LLC (US) | 2015-06-11 | — | — | US | disclosed |
| EP-0857766-B1 | Process for producing aqueous ink for inkjet printing | KAO CORP (JP) | 2005-04-20 | — | — | EP | disclosed |
| WO-2004011513-A1 | GRAFT COPOLYMERS, THEIR PREPARATION AND USE IN CAPILLARY ELECTROPHORESIS | APPLERA CORPORATION (US) | 2004-02-05 | — | — | WO | disclosed |
| US-5998501-A | DISSOLVING POLYMER AND HYDROPHOBIC DYE IN WATER INSOLUBLE SOLVENT; ADDING WATER AND NEUTRALIZING AGENT; EMULSIFICATION; DESOLVENTIZING | KAO CORPORATION (JP) | 1999-12-07 | — | — | US | disclosed |
| EP-0857766-A1 | Process for producing aqueous ink for inkjet printing | KAO CORPORATION (JP) | 1998-08-12 | — | — | EP | disclosed |
| US-5198435-A | Antiinflammatory, antiallergen | G. D. SEARLE & CO. (US) | 1993-03-30 | — | — | US | disclosed |
| EP-0190684-B1 | BICYCLOALKYL, TRICYCLOALKYL, AZABICYCLOALKYL AND AZATRICYCLOALKYL AMIDES | G.D. Searle & Co. (US) | 1990-07-25 | — | — | EP | disclosed |
| EP-0190684-A2 | Bicycloalkyl, tricycloalkyl, azabicycloalkyl and azatricycloalkyl amides | G.D. Searle & Co. (US) | 1986-08-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250001400-A1 | MATERIAL AND METHOD FOR PERFORMING A SEPARATION BASED ON BORON CLUSTERS | CCNB1, CCNB2, CCNB3 | L3MBTL1 2086/4885HSD17B10 4027/4885HSD11B1 3008/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.